Technological Advancements in the Identification Techniques and Increasing R&D Expenditure are expected to drive the Global Parasitology Identification Market in the forecast period of 2019-2026

Global Parasitology Identification Market is projected to register a healthy CAGR of 10.9% in the forecast period of 2019 to 2026. The new market report contains data for the historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Access Full Report at https://databridgemarketresearch.com/reports/global-parasitology-identification-market

Drivers: Global Parasitology Identification Market

  • Increasing R&D expenditure
  • Technological advancements in the identification techniques

Restraints:

  • Stringent regulations
  • High cost of devices

Opportunity:

  • Improving better healthcare outcomes in emerging countries

Challenge:

  • Adoption of new technologies in the developing countries

Market Trends:

Global parasitology identification market is segmented into five notable segments which are products, methods, pathogen type, sample and end user.

  • On the basis of products, the market is segmented into devices, consumables & accessories. The consumables and accessories segment are dominating the market.
  • On the basis of methods, the market is segmented into fecal identification, morphological identification, molecular techniques, MALDI-TOF MS, immunological techniques, rapid diagnostic tests (RDTs), others.
  • On the basis of pathogen type, the market is segmented into Protozoan, Helminths, Arthropodes.
  • On the basis of sample, the market is segmented into feces, blood, urine, others.
  • On the basis of end user, the market is segmented into diagnostics centers, hospitals, clinics and others.

Major Players: Global Parasitology Identification Market

Some of the major players operating in this market are Meridian Bioscience Inc., Orgentec Diagnostika GmbH, Trinity Biotech, VWR International, LLC., Eurofins Scientific, Tecan Trading AG, BD, Thermo Fisher Scientific Inc., VIRION/SERION, altona Diagnostics GmbH, Bio-Rad Laboratories, Inc., Quest Diagnostics Incorporated, Shimadzu Corporation, Luminex Corporation, Abbott, Creative Diagnostics, Bruker, bioMérieux SA, Liferiver Bio-Tech (United States) Corp., Biomerica, Inc., R-Biopharm and others.